Zebrafish-based small molecule screens for novel cardiovascular drugs

Drug Discovery Today: Technologies

Volumn 10, Issue 1, 2013, Pages

  Novodvorsky, Peter ^a,b   Da Costa, Marc M J ^a,b   Chico, Timothy J A ^a,b  

^a Centre for Developmental and Biomedical Genetics   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 BENZYLIDENE 3 (CYCLOHEXYLAMINO) 2,3 DIHYDRO 1H INDEN 1 ONE; 2 METHOXY N (4 METHYLPHENYL)BENZAMIDE; 2 MORPHOLINO 8 PHENYLCHROMONE; ADALIMUMAB; ALBENDAZOLE; ANGIOGENESIS INHIBITOR; ANGIOGENIC FACTOR; ANTIARRHYTHMIC AGENT; APLEXONE; ARISTOLOCHIC ACID; BT 10; CARDIOVASCULAR AGENT; COLEON A; COMPACTIN; DIHYDROMUNDULETONE; EMODIN; ENALAPRIL MALEATE; FLUDROXYCORTIDE; INFLIXIMAB; ISOROTENONE; MEBENDAZOLE; MEVINOLIN; NATURAL PRODUCT; PYROGALLIN; RETINOIC ACID DERIVATIVE; ROSUVASTATIN; SIMVASTATIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; XYLOKETAL DERIVATIVE; ZEARALENONE;

CARDIOVASCULAR SYSTEM; DRUG EFFECT; DRUG SCREENING; EMBRYO DEVELOPMENT; EXPERIMENTAL MODEL; FERTILIZATION; GENE EXPRESSION; HEART DEVELOPMENT; HUMAN; IN VIVO STUDY; LONG QT SYNDROME; NONHUMAN; REVIEW; ZEBRA FISH;

ANIMALS; CARDIOVASCULAR AGENTS; DRUG EVALUATION, PRECLINICAL; HIGH-THROUGHPUT SCREENING ASSAYS; ZEBRAFISH;

EID: 84875720647     PISSN: None     EISSN: 17406749     Source Type: Journal    
DOI: 10.1016/j.ddtec.2012.01.005     Document Type: Review

References (32)

1. G. Streisinger Production of clones of homozygous diploid zebra fish (Brachydanio rerio) Nature 291 1981 293 296
2. C.G. Burns High-throughput assay for small molecules that modulate zebrafish embryonic heart rate Nat. Chem. Biol. 1 2005 263 264
3. N.D. Lawson, and B.M. Weinstein In vivo imaging of embryonic vascular development using transgenic zebrafish Dev. Biol. 248 2002 307 318
4. Y. Blum Complex cell rearrangements during intersegmental vessel sprouting and vessel fusion in the zebrafish embryo Dev. Biol. 316 2008 312 322
5. Q. Long GATA-1 expression pattern can be recapitulated in living transgenic zebrafish using GFP reporter gene Development 124 1997 4105 4111
6. R.T. Peterson Small molecule developmental screens reveal the logic and timing of vertebrate development Proc. Natl. Acad. Sci. U. S. A. 97 2000 12965 12969
7. D.Y. Stainier, and M.C. Fishman The zebrafish as a model system to study cardiovascular development Trends Cardiovasc. Med. 4 1994 207 212
8. T.V. Bowman, and L.I. Zon Swimming into the future of drug discovery: in vivo chemical screens in zebrafish ACS Chem. Biol. 5 2010 159 161
9. J.H. Postlethwait Vertebrate genome evolution and the zebrafish gene map Nat. Genet. 18 1998 345 349
10. D.M. Roden, and R. Temple The US Food and Drug Administration Cardiorenal Advisory Panel and the drug approval process Circulation 111 2005 1697 1702
11. D.S. Peal Novel chemical suppressors of long QT syndrome identified by an in vivo functional screen Circulation 123 2011 23 30
12. R. Kopp Cardiac performance in the zebrafish breakdance mutant J. Exp. Biol. 208 Pt 11 2005 2123 2134
13. J.D. Clifton Identification of novel inhibitors of dietary lipid absorption using zebrafish PLoS ONE 5 2010 e12386
14. G.N. Serbedzija Zebrafish angiogenesis: a new model for drug screening Angiogenesis 3 1999 353 359
15. Y. Lin Five unique compounds: xyloketals from mangrove fungus Xylaria sp. from the South China Sea coast J. Org. Chem. 66 2001 6252 6256
16. W.L. Chen A novel marine compound xyloketal B protects against oxidized LDL-induced cell injury in vitro Biochem. Pharmacol. 78 2009 941 950
17. Z. Xu Design and synthesis of novel xyloketal derivatives and their vasorelaxing activities in rat thoracic aorta and angiogenic activities in zebrafish angiogenesis screen J. Med. Chem. 53 2010 4642 4653
18. J. Choi Aplexone targets the HMG-CoA reductase pathway and differentially regulates arteriovenous angiogenesis Development 138 2011 1173 1181
19. A.C. Santos, and R. Lehmann Isoprenoids control germ cell migration downstream of HMGCoA reductase Dev. Cell 6 2004 283 293
20. J.L. Thorpe Germ cell migration in zebrafish is dependent on HMGCoA reductase activity and prenylation Dev. Cell 6 2004 295 302
21. S.S. Kitambi Small molecule screen for compounds that affect vascular development in the zebrafish retina Mech. Dev. 126 2009 464 477
22. C. Wang Rosuvastatin, identified from a zebrafish chemical genetic screen for antiangiogenic compounds, suppresses the growth of prostate cancer Eur. Urol. 58 2010 418 426
23. K.K.W. Chan The statins as anticancer agents Clin. Cancer Res. 9 2003 10 19
24. Y. Alvarez Selective inhibition of retinal angiogenesis by targeting PI3 kinase PLoS ONE 4 2009 e7867
25. S. Childs Patterning of angiogenesis in the zebrafish embryo Development 129 2002 973 982
26. J.E. Cannon Intersegmental vessel formation in zebrafish: requirement for VEGF but not BMP signalling revealed by selective and non-selective BMP antagonists Br. J. Pharmacol. 161 2010 140 149
27. A.D. Crawford Zebrafish bioassay-guided natural product discovery: isolation of angiogenesis inhibitors from East African medicinal plants PLoS ONE 6 2011 e14694
28. B. Thisse, and C. Thisse Functions and regulations of fibroblast growth factor signaling during embryonic development Dev. Biol. 287 2005 390 402
29. L. Dailey Mechanisms underlying differential responses to FGF signaling Cytokine Growth Factor Rev. 16 2005 233 247
30. G. Molina Zebrafish chemical screening reveals an inhibitor of Dusp6 that expands cardiac cell lineages Nat. Chem. Biol. 5 2009 680 687
31. E. Kwong Strategies for bringing drug delivery tools into discovery Int. J. Pharmaceutics 412 2011 1 7
32. B.C. Das A forward chemical screen in zebrafish identifies a retinoic acid derivative with receptor specificity PLoS ONE 5 2010 e10004